TLIS - Talis Biomedical Corporation Stock Price, Fair Value and News

$1.72-0.12 (-6.52%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

TLIS Price Action

Last 7 days

0.6%

Last 30 days

0.6%

Last 90 days

-7.0%

Trailing 12 Months

-78.5%

TLIS RSI Chart

TLIS Valuation

Market Cap

54.5M

TLIS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

TLIS Fundamentals

TLIS Revenue

Rev. Growth (Yr)

-94.01%

TLIS Earnings

Earnings Growth (Yr)

41.14%

Earnings Growth (Qtr)

32.11%

TLIS Profitability

TLIS Investor Care

Shares Dilution (1Y)

731.68%

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	0	0	0	0
2023	0	0	0	2.1M
2022	0	0	0	4.8M
2021	0	0	0	8.2M
2020	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

About Talis Biomedical Corporation

Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also develops Talis One tests for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A and influenza B. The company was incorporated in 2013 and is headquartered in Redwood, California.

CEO	Mr. Robert Kelley MBA
WEBSITE	https://talisbio.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	102

Talis Biomedical Corporation Frequently Asked Questions

What is the ticker symbol for Talis Biomedical Corporation? What does TLIS stand for in stocks?

TLIS is the stock ticker symbol of Talis Biomedical Corporation. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Talis Biomedical Corporation (TLIS)?

As of Fri Dec 20 2024, market cap of Talis Biomedical Corporation is 54.5 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TLIS stock?

You can check TLIS's fair value in chart for subscribers.

Is Talis Biomedical Corporation a good stock to buy?

The fair value guage provides a quick view whether TLIS is over valued or under valued. Whether Talis Biomedical Corporation is cheap or expensive depends on the assumptions which impact Talis Biomedical Corporation's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TLIS.

What is Talis Biomedical Corporation's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, TLIS's PE ratio (Price to Earnings) is 0 and Price to Sales (PS) ratio is 0. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TLIS PE ratio will change depending on the future growth rate expectations of investors.